cannabidoil
Biotech’s stock goes down in flames after cannabidiol drug failure
August 8, 2017Manufacturing and Production, Research and Development GW Pharma, Zynerba, biotech, cannabidoil, drugs, pharma, pharmaceutical
Zynerba Pharmaceuticals had hoped that its anti-seizure therapy could replicate the kind of success leading competitors had achieved in showing …
Cannabidiol drug found to aid in devastating childhood epilepsy condition
May 25, 2017Research and Development GW Pharmaceuticals, cannabidoil, epilepsy
A treatment derived from cannabis has been found to produce remarkable results in children who have epilepsy. Cannabidoil, when offered …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
